These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 10845872

  • 1. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
    Böger RH, Bode-Böger SM, Sydow K, Heistad DD, Lentz SR.
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
    [Abstract] [Full Text] [Related]

  • 2. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
    Sydow K, Schwedhelm E, Arakawa N, Bode-Böger SM, Tsikas D, Hornig B, Frölich JC, Böger RH.
    Cardiovasc Res; 2003 Jan; 57(1):244-52. PubMed ID: 12504835
    [Abstract] [Full Text] [Related]

  • 3. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
    Stühlinger MC, Stanger O.
    Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
    [Abstract] [Full Text] [Related]

  • 4. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
    Lentz SR, Malinow MR, Piegors DJ, Bhopatkar-Teredesai M, Faraci FM, Heistad DD.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278
    [Abstract] [Full Text] [Related]

  • 5. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.
    Böger RH, Lentz SR, Bode-Böger SM, Knapp HR, Haynes WG.
    Clin Sci (Lond); 2001 Feb; 100(2):161-7. PubMed ID: 11171285
    [Abstract] [Full Text] [Related]

  • 6. Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
    Yoo JH, Lee SC.
    Atherosclerosis; 2001 Oct; 158(2):425-30. PubMed ID: 11583722
    [Abstract] [Full Text] [Related]

  • 7. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
    Stühlinger MC, Oka RK, Graf EE, Schmölzer I, Upson BM, Kapoor O, Szuba A, Malinow MR, Wascher TC, Pachinger O, Cooke JP.
    Circulation; 2003 Aug 26; 108(8):933-8. PubMed ID: 12912818
    [Abstract] [Full Text] [Related]

  • 8. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
    Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD.
    J Clin Invest; 1996 Jul 01; 98(1):24-9. PubMed ID: 8690798
    [Abstract] [Full Text] [Related]

  • 9. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
    Sydow K, Böger RH.
    Z Kardiol; 2001 Jan 01; 90(1):1-11. PubMed ID: 11220081
    [Abstract] [Full Text] [Related]

  • 10. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP.
    Diabetes Care; 1998 May 01; 21(5):841-8. PubMed ID: 9589252
    [Abstract] [Full Text] [Related]

  • 11. Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.
    Doshi S, McDowell I, Goodfellow J, Stabler S, Boger R, Allen R, Newcombe R, Lewis M, Moat S.
    Metabolism; 2005 Mar 01; 54(3):351-60. PubMed ID: 15736113
    [Abstract] [Full Text] [Related]

  • 12. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P, Nawroth PP.
    Diabetes Care; 1997 Dec 01; 20(12):1880-6. PubMed ID: 9405911
    [Abstract] [Full Text] [Related]

  • 13. ADMA and hyperhomocysteinemia.
    Dayal S, Lentz SR.
    Vasc Med; 2005 Jul 01; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [Abstract] [Full Text] [Related]

  • 14. Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease.
    Ziegler S, Mittermayer F, Plank C, Minar E, Wolzt M, Schernthaner GH.
    J Clin Endocrinol Metab; 2005 Apr 01; 90(4):2175-8. PubMed ID: 15634723
    [Abstract] [Full Text] [Related]

  • 15. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.
    Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA.
    Circulation; 1997 Mar 04; 95(5):1119-21. PubMed ID: 9054838
    [Abstract] [Full Text] [Related]

  • 16. Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease.
    Stanger OH, Semmelrock HJ, Rehak P, Tiran B, Meinitzer A, Rigler B, Tiran A.
    Atherosclerosis; 2002 May 04; 162(1):157-62. PubMed ID: 11947909
    [Abstract] [Full Text] [Related]

  • 17. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
    Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW.
    Am J Kidney Dis; 1999 Oct 04; 34(4):669-77. PubMed ID: 10516348
    [Abstract] [Full Text] [Related]

  • 18. Hyperhomocyst(e)inemia induces multiorgan damage.
    Miller A, Mujumdar V, Shek E, Guillot J, Angelo M, Palmer L, Tyagi SC.
    Heart Vessels; 2000 Oct 04; 15(3):135-43. PubMed ID: 11289502
    [Abstract] [Full Text] [Related]

  • 19. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A.
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr 04; 240(4):286-90. PubMed ID: 11981642
    [Abstract] [Full Text] [Related]

  • 20. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K, Hornig B, Arakawa N, Bode-Böger SM, Tsikas D, Münzel T, Böger RH.
    Vasc Med; 2004 May 04; 9(2):93-101. PubMed ID: 15521698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.